MURRIETA, CA--(MARKET WIRE)--Jul 29, 2008 -- CLX Medical, Inc. (OTC BB:CLXN.OB - News), which is focused on the launch and distribution of unique medical diagnostic testing products, today announced that management of the company is attending the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo being held this week at the Walter E. Washington Convention Center in Washington, DC.

While attending the event, CLX Medical management will meet with the company that has been targeted to serve as the sole importer of CLX's subsidiary products into the European market. The master distributor will provide product support and product packaging control; coordinate sales to other European distributors; distribute products in its own territory; act as the registered EU representative for CE marked products; and assist with the development and implementation of pricing structures.

CLX expects to enter into a master distributor agreement in the next several weeks and will announce name of the European distributor at that time.

AACC is a leading professional society dedicated to improving healthcare through laboratory medicine. Its nearly 10,000 members are clinical laboratory professionals, physicians, research scientists, and others involved in developing tests and directing laboratory operations.

The event is expected to attract more than 20,000 clinical laboratorians, physicians, research scientists, and other health care professionals. The 2008 program features more than 200 educational sessions examining the latest information on a wide range of clinical laboratory testing developments, including aging, cancer, chronic disease management, diabetes, global health issues, and infectious diseases. A complete list of topics being covered at the event is available at http://direct.aacc.org/am/AMBrowse.aspx?Dim=edtopics.

The annual meeting also features AACC's Clinical Lab Expo. The largest gathering of laboratory industry companies in the world, the 2008 Expo is proving to be larger than ever with over 1,800 booths and 650 exhibitors. The Expo allows visitors to see and speak to world-leading companies about the latest developments in laboratory medicine.

"We are pleased to be attending the AACC event, where new science and technology related to clinical diagnostics and additional areas of laboratory medicine will be on display," stated Vera Leonard, chief executive officer of CLX Medical. "In addition to seeing the exhibits at the Clinical Lab Expo, we have an opportunity to speak with leading companies in the industry, including our targeted master distributor, who is also attending the event."

To sign up to receive information by email directly from CLX Medical, Inc. when new press releases, investor newsletters, SEC filings, or other information is disclosed, please visit http://www.clxinvestments.com/email.php.

About CLX Medical, Inc.

CLX Medical, Inc. (www.clxinvestments.com) holds a 51% equity interest in Zonda, Inc., which has developed rapid point of care tests for medical and non-medical markets, and CLX recently announced a letter of intent to acquire another rapid diagnostic device for the medical market. CLX has also invested, and holds a common stock position, in ActionView International, Inc. (www.actionviewinternational.com), a publicly traded global manufacturer and marketer of "smart" scrolling advertising billboards.

All statements included in this release, including statements regarding potential future plans and objectives of CLX Medical, Inc. are forward-looking statements. Such statements are necessarily subject to risks and uncertainties, some of which are significant in scope and nature beyond CLX Medical's control. There can be no assurance that such statements will prove accurate. Actual results and future events could differ materially from those anticipated in such statements depending on many factors. Historical results are not necessarily indicative of future performance.

     Contact:
     Gemini Financial Communications, Inc.
     A. Beyer
     951-677-8073
     Email Contact